Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature

This study is evaluating a new continuous glucose monitoring (CGM) system called the Eversense Gemini, which is a sensor implanted under the skin that can also be read with a quick scan — similar to how flash glucose monitors work. It is designed for people with diabetes who want long-term glucose tracking without daily finger pricks. **You may be eligible if...** - You are 18 years of age or older - You have been diagnosed with diabetes (any type) for at least one year - You have signed an informed consent form and are willing to follow the study protocol **You may NOT be eligible if...** - You had a severe low blood sugar episode (causing loss of consciousness or seizure) in the last 6 months - You were hospitalized for diabetic ketoacidosis in the last 6 months - You have gastroparesis (delayed stomach emptying) - You are pregnant, planning to become pregnant, or breastfeeding - You have a serious heart condition, recent stroke or heart attack, or uncontrolled high blood pressure - You have a condition that would interfere with placing the sensor under the skin Talk to your doctor to see if this trial is right for you.